SMAD3 and breast cancer: Mechanistically, cyclin E-CDK2 and cyclin D1-CDK4/6 complexes can suppress Smad3 through its phosphorylation, and the suppression of Smad3 releases the Rb1-E2F blockade and restore cell cycle arrest in breast cancer cells (53, 56).